Literature DB >> 122680

Penicillamine types in the sclerodermas.

T H Tio1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122680      PMCID: PMC1543604     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  11 in total

Review 1.  The biosynthesis of collagen. 3.

Authors:  M E Grant; D J Prockop
Journal:  N Engl J Med       Date:  1972-02-10       Impact factor: 91.245

2.  Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases.

Authors:  H Tio; L van Wijk; E de Haan
Journal:  Acta Med Scand       Date:  1973-05

3.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

4.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

5.  Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.

Authors:  J Uitto; P Helin; O Rasmussen; I Lorenzen
Journal:  Ann Clin Res       Date:  1970-09

6.  D-penicillamine induced Goodpasture's syndrome in Wilson's disease.

Authors:  I Sternlieb; B Bennett; I H Scheinberg
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

7.  Collagenase in scleroderma.

Authors:  A H Brady
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

8.  Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis.

Authors:  I Mohammed; D Barraclough; E J Holborow; B M Ansell
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

9.  Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

Authors:  R C Bucknall; J Dixon A St; E N Glick; J Woodland; D W Zutshi
Journal:  Br Med J       Date:  1975-03-15

10.  Immunostimulant therapy with levamisole for rheumatoid arthritis.

Authors:  E C Huskisson; J Scott; H W Balme; P A Dieppe; J Trapnell; D A Willoughby
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.